Dopamine and Dopamine Metabolite Level HPCL Measurement Decreased levels of DA in the striatum were found at 6 weeks after the end of PSI treatment as compared to controls (p = 0.02, Figure 6 , panel B ); a decrement was also observed in the level of the dopamine metabolite DOPAC in the PSI-treated rats, but did not reach statistical significance (p = 0.07).
← all excerpts
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study.
1
0.0700
0.0700